← FDA Drug Approvals (Drugs@FDA)
ERAXIS
NDA · New Drug Application · Sponsor: VICURON HOLDINGS · Approved 2006-02-17
Drug application
- FDA Application #
NDA021632- Application type
- New Drug Application
- Brand name
- ERAXIS
- Generic name
- ANIDULAFUNGIN
- Active ingredients
- ANIDULAFUNGIN
- Dosage form
- POWDER
- Route
- INTRAVENOUS
- Marketing status
- Prescription
- Sponsor
- VICURON HOLDINGS
- Manufacturer
- Roerig
- First approval
- 2006-02-17
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown